Description

Risdiplam is an oral medication used to treat spinal muscular atrophy (SMA) by increasing the production of survival motor neuron (SMN) protein. It is designed for patients with SMA types 1, 2, and 3, and is administered daily to improve motor function and overall health.

Interpreter Notes

Interpreters should be aware that Risdiplam may be referred to by its brand name in various contexts. It is important to maintain a formal register when discussing this medication, as it is used in clinical settings. Avoid colloquial terms that may confuse patients, and stick to the glossary term for clarity.

Example Sentences

EN: The doctor prescribed Risdiplam to improve the patient's motor function.

ES: El médico recetó Risdiplam para mejorar la función motora del paciente.

Common Interpreter Mistakes

Confusing Risdiplam with other SMA treatments; mispronouncing the name leading to misunderstandings; using informal language when discussing a prescription.